Advertisement

Topics

FDA Approves Heron’s Cinvanti Injectable Emulsion for the Prevention of Acute and Delayed CINV

09:41 EST 10 Nov 2017 | Speciality Pharma Journal

SAN DIEGO–(BUSINESS WIRE)–Heron Therapeutics, Inc. (Nasdaq: HRTX) (the Company or Heron), a commercial-stage biotechnology company focused on developing novel, best-in-class treatments to address some of the most important unmet patient needs, today announced that the U.S. Food and Drug Administration (FDA) has approved CINVANTI™ (aprepitant) injectable emulsion, for intravenous infusion. CINVANTI is a substance P/neurokinin-1 …

Original Article: FDA Approves Heron’s Cinvanti Injectable Emulsion for the Prevention of Acute and Delayed CINV

NEXT ARTICLE

More From BioPortfolio on "FDA Approves Heron’s Cinvanti Injectable Emulsion for the Prevention of Acute and Delayed CINV"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...